词条 | Approvable letter |
释义 |
Approvable and non-approvable letters are covered under Title 21 of the Code of Federal Regulations, section 314.110.[3] GuidelinesApprovable letters are issued to applicants at the end of the FDA's review period to indicate that the application or abbreviated application is basically approvable providing certain issues are resolved. It's an indication that the application substantially meets FDA requirements if specific conditions, such as labeling changes, are agreed to. The letter describes what is required by the FDA.[3] Applicants have 10 days after the date of the approvable letter to amend the application, notify of intent to file for an extension, withdraw the application, request a hearing or notify that they agree to an extension.[3] References1. ^1 {{cite web|url=https://www.nytimes.com/2008/07/10/business/10drug.html |title=F.D.A. Revises Its Letter for Nonapproval of Drugs |website=nytimes.com |date=2008-07-10 |accessdate=2018-09-28}} {{pharma-stub|date=September 2018}}2. ^{{cite web|url=http://www.ophthalmologytimes.com/ophthalmologytimes/content/fda-issues-non-approvable-letter-istas-t-pred |title=FDA issues non-approvable letter for ISTA's T-Pred |website=ophthalmologytimes.com |date=2007-05-05 |accessdate=2018-09-28}} 3. ^1 2 {{cite web|url=https://www.gpo.gov/fdsys/pkg/CFR-2006-title21-vol5/xml/CFR-2006-title21-vol5-sec314-110.xml |title=Title 21 - Food and Drugs. CHAPTER I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED). SUBCHAPTER D - DRUGS FOR HUMAN USE. PART 314 - APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG. Subpart D - FDA Action on Applications and Abbreviated Applications. |website=gpo.gov |date=2006-04-01 |accessdate=2018-09-28}} 1 : Food and Drug Administration |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。